

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.70948341 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.62359452 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.34931399 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.12487132 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.11658454 |
| 6 | glutamate secretion (GO:0014047) | 4.96032925 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.94715392 |
| 8 | vocalization behavior (GO:0071625) | 4.92152153 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.82932813 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.64212075 |
| 11 | protein localization to synapse (GO:0035418) | 4.63103348 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.61229610 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.53791125 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38352708 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.31256932 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.30011016 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24841278 |
| 18 | exploration behavior (GO:0035640) | 4.21961701 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.10142278 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.07631126 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.04070374 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02951906 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 3.99617220 |
| 24 | proline transport (GO:0015824) | 3.98622392 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.93405894 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.86887561 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.86725633 |
| 28 | L-amino acid import (GO:0043092) | 3.81706886 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.81171797 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.74125481 |
| 31 | cellular sodium ion homeostasis (GO:0006883) | 3.69407884 |
| 32 | amino acid import (GO:0043090) | 3.67605839 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.64119222 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62435378 |
| 35 | sodium ion export (GO:0071436) | 3.62405370 |
| 36 | neuron recognition (GO:0008038) | 3.59161914 |
| 37 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.57702758 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.56408883 |
| 39 | positive regulation of dendritic spine development (GO:0060999) | 3.56098089 |
| 40 | activation of protein kinase A activity (GO:0034199) | 3.53713124 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50129405 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49028928 |
| 43 | innervation (GO:0060384) | 3.48767722 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46207957 |
| 45 | long-term memory (GO:0007616) | 3.45677388 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.45579083 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44019998 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.42857611 |
| 49 | cell communication by electrical coupling (GO:0010644) | 3.41402477 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.38372160 |
| 51 | neurotransmitter transport (GO:0006836) | 3.37947776 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.34463885 |
| 53 | membrane depolarization during action potential (GO:0086010) | 3.34026054 |
| 54 | positive regulation of membrane potential (GO:0045838) | 3.33569857 |
| 55 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.32487707 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.31947357 |
| 57 | axonal fasciculation (GO:0007413) | 3.31828355 |
| 58 | cell communication involved in cardiac conduction (GO:0086065) | 3.31679687 |
| 59 | regulation of synaptic plasticity (GO:0048167) | 3.30133301 |
| 60 | central nervous system myelination (GO:0022010) | 3.29045856 |
| 61 | axon ensheathment in central nervous system (GO:0032291) | 3.29045856 |
| 62 | neuromuscular synaptic transmission (GO:0007274) | 3.27882793 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.24740716 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.24671738 |
| 65 | vesicle transport along microtubule (GO:0047496) | 3.23642261 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.22878027 |
| 67 | cell migration in hindbrain (GO:0021535) | 3.22691076 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.21579502 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.19466133 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17185325 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.16686778 |
| 72 | transmission of nerve impulse (GO:0019226) | 3.16341336 |
| 73 | potassium ion import (GO:0010107) | 3.15239408 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.13092857 |
| 75 | neuromuscular process controlling posture (GO:0050884) | 3.13084728 |
| 76 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.13080905 |
| 77 | dendrite morphogenesis (GO:0048813) | 3.12884691 |
| 78 | auditory behavior (GO:0031223) | 3.08271491 |
| 79 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.07105157 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06119116 |
| 81 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05689318 |
| 82 | regulation of neurotransmitter levels (GO:0001505) | 3.05635841 |
| 83 | organelle transport along microtubule (GO:0072384) | 3.04904594 |
| 84 | membrane depolarization (GO:0051899) | 3.04612013 |
| 85 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.04462894 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.01962433 |
| 87 | regulation of dendritic spine development (GO:0060998) | 3.01796944 |
| 88 | axon cargo transport (GO:0008088) | 3.00445255 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97537632 |
| 90 | neurofilament cytoskeleton organization (GO:0060052) | 2.97490046 |
| 91 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93968241 |
| 92 | postsynaptic membrane organization (GO:0001941) | 2.93915290 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93835384 |
| 94 | behavioral defense response (GO:0002209) | 2.92904443 |
| 95 | behavioral fear response (GO:0001662) | 2.92904443 |
| 96 | glycine transport (GO:0015816) | 2.91970877 |
| 97 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.91370080 |
| 98 | mating behavior (GO:0007617) | 2.90070718 |
| 99 | positive regulation of vesicle fusion (GO:0031340) | 2.89224713 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 2.88985556 |
| 101 | synapse assembly (GO:0007416) | 2.87569987 |
| 102 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.86152724 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 2.86036386 |
| 104 | synaptic transmission (GO:0007268) | 2.84442343 |
| 105 | neuromuscular process (GO:0050905) | 2.84214723 |
| 106 | detection of calcium ion (GO:0005513) | 2.83015251 |
| 107 | presynaptic membrane organization (GO:0097090) | 2.82078769 |
| 108 | neuronal ion channel clustering (GO:0045161) | 2.81650507 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.81133326 |
| 110 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.80906684 |
| 111 | chemosensory behavior (GO:0007635) | 2.80682941 |
| 112 | positive regulation of neurotransmitter transport (GO:0051590) | 2.80182497 |
| 113 | potassium ion homeostasis (GO:0055075) | 2.79812391 |
| 114 | response to auditory stimulus (GO:0010996) | 2.79056140 |
| 115 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.78941642 |
| 116 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.78939319 |
| 117 | regulation of synaptic transmission (GO:0050804) | 2.78835977 |
| 118 | acidic amino acid transport (GO:0015800) | 2.77579573 |
| 119 | learning (GO:0007612) | 2.77358516 |
| 120 | fear response (GO:0042596) | 2.76708288 |
| 121 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.76689180 |
| 122 | positive regulation of synaptic transmission (GO:0050806) | 2.76676103 |
| 123 | dendritic spine organization (GO:0097061) | 2.76334071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.67779893 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47881236 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08351906 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02022981 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00117611 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72728855 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72728855 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.63220639 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62377672 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56558447 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53874195 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50822756 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48927663 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43363442 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41718146 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40269550 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.35441948 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23154401 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21697576 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19545248 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13951870 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13087295 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92346410 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88971929 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82791319 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82486796 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77399734 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75562948 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74535336 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70344455 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69878573 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69734345 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68512953 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61110720 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59082190 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57770995 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50529291 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46816378 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44793901 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44451594 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38906581 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36017867 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34014398 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32217447 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31634988 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30411847 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30011633 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29983324 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28459974 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26758382 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25430032 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25234177 |
| 53 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23291462 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22951798 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22066291 |
| 56 | AR_19668381_ChIP-Seq_PC3_Human | 1.22007052 |
| 57 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21826798 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19817003 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.18563552 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18549048 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17917571 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17609419 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16512730 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14894737 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14275537 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13393448 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12454244 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11982880 |
| 69 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11639790 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11586453 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11299889 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10866471 |
| 73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09997302 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09164013 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08728790 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08634648 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07979318 |
| 78 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07914761 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07270141 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06972964 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06743087 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06468569 |
| 83 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06413298 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06098842 |
| 85 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.05671801 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05292163 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04997143 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04996840 |
| 89 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02921527 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02637250 |
| 91 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.00130563 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98786835 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98687401 |
| 94 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97916763 |
| 95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97228550 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96485384 |
| 97 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95651457 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95524258 |
| 99 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94899799 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94303904 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94212765 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94079834 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93446826 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93398564 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92977930 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92294286 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91368690 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90887994 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87022218 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86547338 |
| 111 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.86351854 |
| 112 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85563964 |
| 113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85537788 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85334931 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85334931 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83509993 |
| 117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83013779 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.82962671 |
| 119 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80530847 |
| 120 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.80419049 |
| 121 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.78598969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.16879405 |
| 2 | MP0003880_abnormal_central_pattern | 4.62013330 |
| 3 | MP0004270_analgesia | 4.02051537 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.94156203 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.50023578 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.11264473 |
| 7 | MP0009745_abnormal_behavioral_response | 3.06735384 |
| 8 | MP0002064_seizures | 2.91705340 |
| 9 | MP0009046_muscle_twitch | 2.90024785 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.87569313 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.82280740 |
| 12 | MP0002736_abnormal_nociception_after | 2.69458815 |
| 13 | MP0002272_abnormal_nervous_system | 2.66831789 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.64086846 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.56129328 |
| 16 | MP0001486_abnormal_startle_reflex | 2.40207700 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.30431479 |
| 18 | MP0004858_abnormal_nervous_system | 2.21623895 |
| 19 | MP0001970_abnormal_pain_threshold | 2.12003630 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.10833839 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.06433852 |
| 22 | MP0003329_amyloid_beta_deposits | 2.02267508 |
| 23 | MP0006276_abnormal_autonomic_nervous | 2.02103700 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.96608200 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.96027995 |
| 26 | MP0002184_abnormal_innervation | 1.91824395 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.86869523 |
| 28 | MP0000778_abnormal_nervous_system | 1.81722739 |
| 29 | MP0002822_catalepsy | 1.81168303 |
| 30 | MP0008569_lethality_at_weaning | 1.79847477 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.79557698 |
| 32 | MP0000955_abnormal_spinal_cord | 1.63212513 |
| 33 | MP0004924_abnormal_behavior | 1.59403524 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.59403524 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.57666202 |
| 36 | MP0001984_abnormal_olfaction | 1.55356996 |
| 37 | MP0002882_abnormal_neuron_morphology | 1.50426961 |
| 38 | MP0003879_abnormal_hair_cell | 1.43023419 |
| 39 | MP0000751_myopathy | 1.41424198 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.38895918 |
| 41 | MP0003633_abnormal_nervous_system | 1.37552706 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.37464105 |
| 43 | MP0004885_abnormal_endolymph | 1.34780053 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.28307659 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.21923647 |
| 46 | MP0002229_neurodegeneration | 1.21064208 |
| 47 | MP0003787_abnormal_imprinting | 1.18978413 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.18211512 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.16651562 |
| 50 | MP0003631_nervous_system_phenotype | 1.14658555 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.11245876 |
| 52 | MP0004142_abnormal_muscle_tone | 1.11057542 |
| 53 | MP0003123_paternal_imprinting | 1.08655357 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.06239298 |
| 55 | MP0003122_maternal_imprinting | 1.03327855 |
| 56 | MP0003634_abnormal_glial_cell | 1.03325452 |
| 57 | MP0002152_abnormal_brain_morphology | 1.02776009 |
| 58 | MP0001346_abnormal_lacrimal_gland | 0.98815188 |
| 59 | MP0001905_abnormal_dopamine_level | 0.98476610 |
| 60 | MP0001529_abnormal_vocalization | 0.98108126 |
| 61 | MP0004215_abnormal_myocardial_fiber | 0.93945202 |
| 62 | MP0005670_abnormal_white_adipose | 0.93931995 |
| 63 | MP0000920_abnormal_myelination | 0.93368704 |
| 64 | MP0002752_abnormal_somatic_nervous | 0.93039211 |
| 65 | MP0004085_abnormal_heartbeat | 0.90578577 |
| 66 | MP0002090_abnormal_vision | 0.89977398 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.89870598 |
| 68 | MP0005623_abnormal_meninges_morphology | 0.89320746 |
| 69 | MP0005535_abnormal_body_temperature | 0.89091632 |
| 70 | MP0005409_darkened_coat_color | 0.88965482 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 0.87797004 |
| 72 | MP0000604_amyloidosis | 0.87742913 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.87202808 |
| 74 | MP0003283_abnormal_digestive_organ | 0.86526269 |
| 75 | MP0004233_abnormal_muscle_weight | 0.84351185 |
| 76 | MP0001188_hyperpigmentation | 0.83535728 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.82912184 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.82707679 |
| 79 | MP0008874_decreased_physiological_sensi | 0.81682448 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.81524019 |
| 81 | MP0004742_abnormal_vestibular_system | 0.80638793 |
| 82 | MP0004484_altered_response_of | 0.79959248 |
| 83 | MP0008872_abnormal_physiological_respon | 0.78282343 |
| 84 | MP0003632_abnormal_nervous_system | 0.77980903 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.74924060 |
| 86 | MP0001177_atelectasis | 0.74590297 |
| 87 | MP0000534_abnormal_ureter_morphology | 0.73528498 |
| 88 | MP0003690_abnormal_glial_cell | 0.73197087 |
| 89 | MP0004130_abnormal_muscle_cell | 0.72430718 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.71674976 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.70275688 |
| 92 | MP0005253_abnormal_eye_physiology | 0.69000033 |
| 93 | MP0005499_abnormal_olfactory_system | 0.68964158 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.68964158 |
| 95 | MP0000747_muscle_weakness | 0.67607173 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.66555160 |
| 97 | MP0003075_altered_response_to | 0.66353667 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.62940809 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.61105604 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.60811275 |
| 101 | MP0004043_abnormal_pH_regulation | 0.60069918 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.58936903 |
| 103 | MP0003385_abnormal_body_wall | 0.58518675 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.58296577 |
| 105 | MP0004510_myositis | 0.58266278 |
| 106 | MP0003861_abnormal_nervous_system | 0.57197845 |
| 107 | MP0004036_abnormal_muscle_relaxation | 0.57188654 |
| 108 | MP0003045_fibrosis | 0.56795864 |
| 109 | MP0005187_abnormal_penis_morphology | 0.56601617 |
| 110 | MP0001664_abnormal_digestion | 0.55559796 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.55520535 |
| 112 | MP0010769_abnormal_survival | 0.55095746 |
| 113 | MP0001943_abnormal_respiration | 0.54234043 |
| 114 | MP0010770_preweaning_lethality | 0.53018594 |
| 115 | MP0002082_postnatal_lethality | 0.53018594 |
| 116 | MP0000026_abnormal_inner_ear | 0.51696362 |
| 117 | MP0003938_abnormal_ear_development | 0.51382235 |
| 118 | MP0010768_mortality/aging | 0.51307980 |
| 119 | MP0005171_absent_coat_pigmentation | 0.50095311 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.48116405 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.46943121 |
| 122 | MP0003956_abnormal_body_size | 0.46024310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.67814234 |
| 2 | Myokymia (HP:0002411) | 6.39470278 |
| 3 | Focal seizures (HP:0007359) | 5.39107334 |
| 4 | Action tremor (HP:0002345) | 4.99397873 |
| 5 | Visual hallucinations (HP:0002367) | 4.88887848 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.48586813 |
| 7 | Atonic seizures (HP:0010819) | 4.41443840 |
| 8 | Febrile seizures (HP:0002373) | 4.23926534 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.16578894 |
| 10 | Ulnar claw (HP:0001178) | 4.10760581 |
| 11 | Absence seizures (HP:0002121) | 4.09687844 |
| 12 | Obstructive sleep apnea (HP:0002870) | 4.05317905 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 4.03101790 |
| 14 | Termporal pattern (HP:0011008) | 3.99150196 |
| 15 | Insidious onset (HP:0003587) | 3.99150196 |
| 16 | Dialeptic seizures (HP:0011146) | 3.69775799 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.65855818 |
| 18 | Ankle clonus (HP:0011448) | 3.36815507 |
| 19 | Truncal ataxia (HP:0002078) | 3.09272096 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00800951 |
| 21 | Depression (HP:0000716) | 2.99888152 |
| 22 | Poor eye contact (HP:0000817) | 2.95221644 |
| 23 | Broad-based gait (HP:0002136) | 2.94815014 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.94252830 |
| 25 | Annular pancreas (HP:0001734) | 2.92940811 |
| 26 | Amblyopia (HP:0000646) | 2.88716648 |
| 27 | Dysmetria (HP:0001310) | 2.87182566 |
| 28 | Pheochromocytoma (HP:0002666) | 2.87043809 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.86901882 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.86745056 |
| 31 | Sleep apnea (HP:0010535) | 2.82710782 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.80479035 |
| 33 | Mutism (HP:0002300) | 2.80253437 |
| 34 | Abnormal social behavior (HP:0012433) | 2.75350291 |
| 35 | Impaired social interactions (HP:0000735) | 2.75350291 |
| 36 | Anxiety (HP:0000739) | 2.73720568 |
| 37 | Hyperventilation (HP:0002883) | 2.72031532 |
| 38 | Hand muscle atrophy (HP:0009130) | 2.70518479 |
| 39 | Postural instability (HP:0002172) | 2.68127273 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.67729570 |
| 41 | Urinary urgency (HP:0000012) | 2.65483267 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.63909225 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.60920325 |
| 44 | Papilledema (HP:0001085) | 2.59128008 |
| 45 | Excessive salivation (HP:0003781) | 2.55559582 |
| 46 | Drooling (HP:0002307) | 2.55559582 |
| 47 | Genetic anticipation (HP:0003743) | 2.54000820 |
| 48 | Hammertoe (HP:0001765) | 2.51149694 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.51078397 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.51078397 |
| 51 | Spastic gait (HP:0002064) | 2.50362891 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.47380815 |
| 53 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.46444553 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.43806425 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.42564306 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.42109318 |
| 57 | Hemiparesis (HP:0001269) | 2.39158732 |
| 58 | Cerebral hypomyelination (HP:0006808) | 2.37915161 |
| 59 | Progressive inability to walk (HP:0002505) | 2.37213863 |
| 60 | Akinesia (HP:0002304) | 2.36984126 |
| 61 | Scanning speech (HP:0002168) | 2.35808488 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.33756821 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33596839 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.33414313 |
| 65 | Central scotoma (HP:0000603) | 2.29935497 |
| 66 | Torticollis (HP:0000473) | 2.28977986 |
| 67 | Lower limb amyotrophy (HP:0007210) | 2.27548553 |
| 68 | Lower limb muscle weakness (HP:0007340) | 2.26066921 |
| 69 | Onion bulb formation (HP:0003383) | 2.25669899 |
| 70 | Intention tremor (HP:0002080) | 2.25360982 |
| 71 | Bradykinesia (HP:0002067) | 2.20032548 |
| 72 | Diplopia (HP:0000651) | 2.19970388 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.19970388 |
| 74 | Steppage gait (HP:0003376) | 2.18495498 |
| 75 | Clonus (HP:0002169) | 2.18310512 |
| 76 | Muscle fiber splitting (HP:0003555) | 2.17060293 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.15732893 |
| 78 | Postural tremor (HP:0002174) | 2.15170167 |
| 79 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.14440161 |
| 80 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.14440161 |
| 81 | Rapidly progressive (HP:0003678) | 2.12560557 |
| 82 | Tetraplegia (HP:0002445) | 2.12120151 |
| 83 | Peripheral hypomyelination (HP:0007182) | 2.10220055 |
| 84 | Insomnia (HP:0100785) | 2.07762890 |
| 85 | Focal dystonia (HP:0004373) | 2.06969443 |
| 86 | Megalencephaly (HP:0001355) | 2.05728144 |
| 87 | Absent speech (HP:0001344) | 2.05137168 |
| 88 | Stereotypic behavior (HP:0000733) | 2.04640399 |
| 89 | Spinal cord compression (HP:0002176) | 2.04625872 |
| 90 | Abnormality of the foot musculature (HP:0001436) | 2.04423389 |
| 91 | Incomplete penetrance (HP:0003829) | 2.03723792 |
| 92 | Hemiplegia (HP:0002301) | 2.03672634 |
| 93 | Dysmetric saccades (HP:0000641) | 2.03275592 |
| 94 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.02872837 |
| 95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01899679 |
| 96 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.01047000 |
| 97 | Impaired vibratory sensation (HP:0002495) | 2.00857465 |
| 98 | Bronchomalacia (HP:0002780) | 2.00606414 |
| 99 | Fetal akinesia sequence (HP:0001989) | 1.99590754 |
| 100 | Prolonged QT interval (HP:0001657) | 1.98590834 |
| 101 | Hypoventilation (HP:0002791) | 1.96310363 |
| 102 | Polyphagia (HP:0002591) | 1.96145210 |
| 103 | Gait ataxia (HP:0002066) | 1.95075445 |
| 104 | Congenital stationary night blindness (HP:0007642) | 1.94685062 |
| 105 | Decreased motor nerve conduction velocity (HP:0003431) | 1.93145995 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.92739455 |
| 107 | Agitation (HP:0000713) | 1.90993643 |
| 108 | Inability to walk (HP:0002540) | 1.90783279 |
| 109 | Stridor (HP:0010307) | 1.89836653 |
| 110 | Abnormality of the vocal cords (HP:0008777) | 1.88213057 |
| 111 | Increased circulating renin level (HP:0000848) | 1.87692296 |
| 112 | Generalized myoclonic seizures (HP:0002123) | 1.87581911 |
| 113 | Difficulty running (HP:0009046) | 1.87084342 |
| 114 | Status epilepticus (HP:0002133) | 1.86519482 |
| 115 | Bundle branch block (HP:0011710) | 1.86283978 |
| 116 | Distal sensory impairment (HP:0002936) | 1.85683673 |
| 117 | Craniofacial dystonia (HP:0012179) | 1.84820548 |
| 118 | Hypoplasia of the brainstem (HP:0002365) | 1.84382052 |
| 119 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.84382052 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 1.84169605 |
| 121 | Spinal muscular atrophy (HP:0007269) | 1.84106512 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 1.83197178 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83197178 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83197178 |
| 125 | Apathy (HP:0000741) | 1.81480230 |
| 126 | Abnormal EKG (HP:0003115) | 1.80653624 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.80582707 |
| 128 | Atrioventricular block (HP:0001678) | 1.80353298 |
| 129 | Limb dystonia (HP:0002451) | 1.80235763 |
| 130 | Delusions (HP:0000746) | 1.80042375 |
| 131 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78099256 |
| 132 | Failure to thrive in infancy (HP:0001531) | 1.77865910 |
| 133 | Abnormality of the musculature of the hand (HP:0001421) | 1.77708954 |
| 134 | Heart block (HP:0012722) | 1.75664790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.66620502 |
| 2 | MAP3K9 | 3.89964843 |
| 3 | EPHA4 | 3.46317261 |
| 4 | MAP3K4 | 3.19534513 |
| 5 | MARK1 | 3.15736584 |
| 6 | MINK1 | 3.14019557 |
| 7 | MAP2K7 | 2.45821753 |
| 8 | KSR2 | 2.34462249 |
| 9 | PAK6 | 2.33802682 |
| 10 | NTRK1 | 2.17148824 |
| 11 | MAP2K4 | 2.05484455 |
| 12 | PRKD3 | 2.04730275 |
| 13 | DAPK2 | 2.01363784 |
| 14 | MAP3K12 | 1.99329519 |
| 15 | RIPK4 | 1.87637007 |
| 16 | NTRK2 | 1.73397926 |
| 17 | CAMKK1 | 1.70418029 |
| 18 | CDK5 | 1.56145375 |
| 19 | KSR1 | 1.52183243 |
| 20 | PNCK | 1.48893922 |
| 21 | LATS2 | 1.48698117 |
| 22 | LMTK2 | 1.48572217 |
| 23 | GRK5 | 1.44580940 |
| 24 | MAP3K2 | 1.41929587 |
| 25 | STK38 | 1.41681292 |
| 26 | CASK | 1.39111008 |
| 27 | PHKG2 | 1.36417770 |
| 28 | PHKG1 | 1.36417770 |
| 29 | MAPK13 | 1.30988498 |
| 30 | PLK2 | 1.27516396 |
| 31 | ARAF | 1.26642525 |
| 32 | DAPK1 | 1.25235133 |
| 33 | SIK2 | 1.24894446 |
| 34 | PRKCG | 1.16715630 |
| 35 | RET | 1.16349778 |
| 36 | TNIK | 1.11400448 |
| 37 | FES | 1.10228727 |
| 38 | CDK19 | 1.02691003 |
| 39 | PRPF4B | 1.01548449 |
| 40 | CAMK2A | 0.99673881 |
| 41 | UHMK1 | 0.98281673 |
| 42 | CAMKK2 | 0.97291161 |
| 43 | MAP3K13 | 0.95288574 |
| 44 | SGK223 | 0.91659067 |
| 45 | SGK494 | 0.91659067 |
| 46 | PAK3 | 0.91558268 |
| 47 | PTK2B | 0.88901134 |
| 48 | CDK14 | 0.86573976 |
| 49 | NEK6 | 0.84985897 |
| 50 | TYRO3 | 0.84475726 |
| 51 | PRKCH | 0.83068491 |
| 52 | CDK18 | 0.82759586 |
| 53 | FER | 0.81827837 |
| 54 | CAMK1 | 0.81636853 |
| 55 | CDK15 | 0.81277926 |
| 56 | STK11 | 0.80678336 |
| 57 | CAMK1G | 0.80483989 |
| 58 | WNK1 | 0.79445303 |
| 59 | CAMK2B | 0.76801068 |
| 60 | OXSR1 | 0.74160741 |
| 61 | MAPK12 | 0.73405026 |
| 62 | PINK1 | 0.72919594 |
| 63 | TAOK1 | 0.71723000 |
| 64 | WNK4 | 0.70626697 |
| 65 | PDK1 | 0.70092369 |
| 66 | CDK11A | 0.69468105 |
| 67 | DYRK1A | 0.68849152 |
| 68 | PDGFRA | 0.68756229 |
| 69 | MAP3K1 | 0.68728076 |
| 70 | DDR2 | 0.68177435 |
| 71 | MARK2 | 0.67464722 |
| 72 | RAF1 | 0.67409307 |
| 73 | STK39 | 0.66119183 |
| 74 | SGK2 | 0.64521188 |
| 75 | PDPK1 | 0.63674376 |
| 76 | CAMK4 | 0.61656361 |
| 77 | MAP2K1 | 0.60708259 |
| 78 | SGK1 | 0.60348467 |
| 79 | SCYL2 | 0.60036939 |
| 80 | CSNK1G2 | 0.58837202 |
| 81 | PKN1 | 0.56884907 |
| 82 | PRKCZ | 0.56744632 |
| 83 | SGK3 | 0.56276455 |
| 84 | BMPR2 | 0.56168353 |
| 85 | PRKCE | 0.55739722 |
| 86 | CDC42BPA | 0.55056767 |
| 87 | CAMK2D | 0.53299672 |
| 88 | FGFR2 | 0.52706878 |
| 89 | NME1 | 0.52706793 |
| 90 | ICK | 0.52302309 |
| 91 | TESK1 | 0.49596369 |
| 92 | DAPK3 | 0.48342001 |
| 93 | NEK1 | 0.48285653 |
| 94 | ALK | 0.47533050 |
| 95 | RPS6KA3 | 0.47121669 |
| 96 | MAPK10 | 0.46470130 |
| 97 | FYN | 0.44436353 |
| 98 | BRSK1 | 0.44237655 |
| 99 | MAP3K7 | 0.44117648 |
| 100 | TNK2 | 0.43851775 |
| 101 | MAP3K6 | 0.43185908 |
| 102 | PRKAA1 | 0.42570537 |
| 103 | CAMK2G | 0.42217050 |
| 104 | RPS6KA2 | 0.42198325 |
| 105 | RIPK1 | 0.41849584 |
| 106 | ROCK2 | 0.41169356 |
| 107 | FGR | 0.40926886 |
| 108 | ROCK1 | 0.38802150 |
| 109 | PRKG1 | 0.38645096 |
| 110 | BRAF | 0.38265230 |
| 111 | CSNK1E | 0.36777465 |
| 112 | LIMK1 | 0.35281948 |
| 113 | PTK2 | 0.35031921 |
| 114 | WNK3 | 0.34604832 |
| 115 | ERBB2 | 0.34278711 |
| 116 | PAK2 | 0.33956889 |
| 117 | AKT3 | 0.33685398 |
| 118 | PRKCA | 0.32738801 |
| 119 | PRKCB | 0.32252686 |
| 120 | PDK3 | 0.30287444 |
| 121 | PDK4 | 0.30287444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.38418475 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.14978252 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58250803 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57710736 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53460314 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52390013 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51492758 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.44164544 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.41192197 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.28960415 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.20958897 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14309817 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08978427 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.02707434 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87060873 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85734012 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78835873 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.75167061 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.73418291 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70402793 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67922747 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.62438739 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61445000 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58134650 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54437085 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50018446 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46688422 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43034519 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.37448021 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.35981589 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35428438 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32770194 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29819663 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28880754 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21836594 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21613290 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.17345423 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.16913051 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16584800 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16213603 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07955669 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07142324 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05234166 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02552039 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02349569 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.01314285 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95934286 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91221530 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89761915 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89690366 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87576497 |
| 52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87219622 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86572013 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84290358 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84169322 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80348610 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79040918 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75743201 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75277388 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72951692 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69236447 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69228078 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69146520 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68974942 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67614931 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66547505 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62077336 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61919039 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61265757 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57873878 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57370908 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57063835 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56677716 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55421893 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55012683 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53311277 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51940512 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.51558432 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51490550 |
| 80 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51458860 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49053919 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48097564 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.47174542 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46714652 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46543618 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45173781 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.43908933 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43022822 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40543239 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40517646 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40256366 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40004352 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39536704 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39073795 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.37194108 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34980670 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34151196 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33749350 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32122237 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31893013 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31584604 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.31445004 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30825738 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30748334 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30043655 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29794484 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29618037 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29611047 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29416767 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29070252 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.28921372 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28551738 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25339207 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.25212605 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24834014 |

